Editing Generally recognized as safe (section)

==Enforcement==
When use of a substance does not qualify for the GRAS exemption, it is subject to the premarket approval mandated by the [[Federal Food, Drug, and Cosmetic Act]]. In such circumstances, the FDA can take enforcement action to stop distribution of the food substance and foods containing it on the grounds that such foods are not deemed GRAS or contain an unlawfully added ingredient.<ref>{{cite web |url=https://www.govinfo.gov/content/pkg/FR-1997-04-17/pdf/97-9706.pdf |title=Federal Register Proposed Rules – 62 FR 18937 April 17, 1997 – Substances Generally Recognized as Safe [Docket No. 97N–0103]|publisher=Federal Register, US Department of Health and Human Services|date=17 April 1997|access-date=30 January 2021}}</ref>

An example of a non-GRAS ingredient requiring enforcement actions in the form of [[FDA warning letter]]s to 15 companies in 2019 was [[cannabidiol]],<ref name="fda-cbd">{{cite web |title=FDA warns 15 companies for illegally selling various products containing cannabidiol as agency details safety concerns |url=https://www.fda.gov/news-events/press-announcements/fda-warns-15-companies-illegally-selling-various-products-containing-cannabidiol-agency-details |archive-url=https://web.archive.org/web/20191126162834/https://www.fda.gov/news-events/press-announcements/fda-warns-15-companies-illegally-selling-various-products-containing-cannabidiol-agency-details |url-status=dead |archive-date=26 November 2019 |publisher=US Food and Drug Administration |access-date=30 January 2021 |date=25 November 2019}}</ref> which, as of 2021, had not been established with sufficient scientific evidence of safety as a GRAS ingredient.<ref name="hahn">{{cite web |author1=Stephen M Hahn |title=Better Data for a Better Understanding of the Use and Safety Profile of Cannabidiol (CBD) Products |url=https://www.fda.gov/news-events/fda-voices/better-data-better-understanding-use-and-safety-profile-cannabidiol-cbd-products |archive-url=https://web.archive.org/web/20210108175706/https://www.fda.gov/news-events/fda-voices/better-data-better-understanding-use-and-safety-profile-cannabidiol-cbd-products |url-status=dead |archive-date=8 January 2021 |publisher=US Food and Drug Administration |access-date=30 January 2021 |date=8 January 2021}}</ref>